aura: the income statement

MyFinsight

Aura Biosciences, Inc. (AURA)

For the quarter ending 2025-06-30, AURA made $1,686K in revenue. -$27,099K in net income. Net profit margin of -1607.30%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Currency translation adjustment	8
Unrealized loss on marketable securities	-88
Total other comprehensive loss	-80
Income tax provision, net	48
Research and development	22,882
General and administrative	5,731
Total operating expenses	28,613
Total operating loss	-28,613
Other expense	-36
Interest income, including amortization and accretion income	1,678
Total other income	1,642
Loss before income taxes	-26,971
Net loss	-27,019
Total comprehensive loss	-27,099

Net loss per common share - basic	-0.47
Net loss per common share - diluted	-0.47
Weighted average common stock outstanding - basic	58,015,718
Weighted average common stock outstanding - diluted	58,015,718

Unit: Thousand (K) dollars (except for numbers of shares and EPS)